Health ❯ Pharmaceuticals ❯ GLP-1 Drugs ❯ Semaglutide
Set under the Inflation Reduction Act, the Maximum Fair Prices are projected to save Medicare about $12 billion, with out-of-pocket impacts shaped by plan rules and a new spending cap.